Background In spite of continuing progress in percutaneous coronary intervention (PCI) 
INTRODUCTION
Chronic total occlusion (CTO) of coronary arteries is defined as complete occlusion of coronary vessel with TIMI 0 flow greater than 3 months. 1 Histopathologically, CTOs are characterized by fibrous caps, varying degrees of plaques, and neovascularization, with direct relationship with advancing age of arising and appearance of these disorders. 2 The exact incidence CTOs during routine coronary angiography is not well defined. 3 Angioplasty for this coronary lesion has been avoided for many years, and the guideline suggested that single vessel disease being medically treated and multivessel disease for surgical intervention mainly because of the low success rate of percutaneous coronary interventions (PCI) and high restenosis rates following PCI. 4 In spite of For the left coronary system, extra backup type guiding catheters (extra backup) were preferred and used in most cases. Judkins-type guiding catheters were not used frequently as they typically preclude deep intubation & associated with reduced success with hard fibrocalcific occlusions. Antegrade approach to CTO is the strategy applied in all patients of our study. Contra lateral injection was used in few patients.
DEFINITIONS
1-Technical success was a successful recanalization and dilation of CTO with a residual stenos is of < 20%, and TIMI flow >2 as assessed by quantitative coronary angiography. 10 2-Procedural successes was a technical success with no in hospital MACE. 10 3-MACE was defined as death, MI, stroke and target lesion revascularization (TLR). 10 4-TLR any repeat percutaneous intervention of the target lesion (including 5 mm proximal and distal to the target lesion) or surgical bypass of the target vessel performed for restenosis or other complication involving the target lesion. 11 5-In-stent restenosis: is loss of 50% or more of the diameter of the in-stent lumen at the site of an initially successful intervention. 11 6-Stent Thrombosis is adjudicated according to the Academic Research Consortium (ARC) definitions as definite or probable and by timing of the event: acute (≤ 1 day post-procedure), subacute (2 to ≤ 30 days), late (>30 to ≤ 365 days), and very late (>365 days). 12 7-In hospital mortality is a death within the same hospital admission regardless of cause after revascularization. 13 8-PCI and CABG related MI is arbitrarily defined by elevation of cTn values (>5 × 99th percentile URL) in patients with normal baseline values (≤99th percentile URL) or a rise of cTn values >20% if the baseline values are elevated and are stable or falling. In addition, either (i) symptoms suggestive of myocardial ischemia or (ii) new ischemic ECG changes or (iii) angiographic findings consistent with a procedural complication or (iv) imaging demonstration of new loss of viable myocardium or new regional wall motion abnormality are required. 14 9-Significant CAD was defined as lesion on angiography ≥ 70% diameter narrowing (≥ 50% for left main). 15
CORONARY ARTERY BYPASS GRAFT (CABG)
CABG was performed using extracorporeal cardiopulmonary bypass (CPB). This included a median sternotomy, internal mammary artery (IMA) dissection, and, when appropriate, simultaneous harvesting of the venous and/or radial artery grafts. The most frequently grafted coronary arteries were the epicardial vessels. The potency of a constructed graft was influenced by characteristics of the anastomosed vessel, the outflow area, the graft material, its manipulation and construction. Important coronary characteristics included the internal lumen size, the severity of proximal stenosis, the quality of the wall at the site of anastomosis, and the distal vascular bed. Left internal mammary artery (LIMA) was used for grafting LAD while saphenous vein graft (SVG) was used for LCX or RCA lesions.
Both Groups Were Followed Up For One Year and Assessed Outcomes (At 6months and At 12 Months)
1-Each patient was assessed to changes in class of angina pre and post procedure period.2-Each patient was assessed to changes in class of HF according to NYHA Functional Classification.3-Electrocardiogram was performed for every patient. 4-Echocardiography was performed to assess LV dimensions, EF, and degree of MR.5-Coronary angiography was performed .5-MACE was followed before 6 months if patient was symptomatic additionally to regular follow-up at 6 and 12 months..
Statistical analysis:
Statistical package for social sciences (IBM-SPSS), version 19 IBM-Chicago, USA was used for statistical data analysis. Data were expressed as mean, standard deviation (SD), number and percentage. Mean and standard deviations were used as descriptive value for quantitative data. Student t test was used to compare the means between two groups, and one-way analysis of variance (ANOVA) test was used to compare means of more than two groups. P-value < 0.05 was considered as significant.
RESULTS
Totally, there were 80 patients with LAD CTO at angiography with or without other significant lesions in another coronary artery (left circumflex and/or right coronary artery).. They were divided into 2 groups: 
FOLLOW UP RESULTS

Angina Pectoris CCS class
PCI group
After 6 and 12 months follow up, anginal symptoms were significantly improved; P<0.0001. as shown in Table ( 6) and figure (1), 2 patients died at 6 month follow up.
CABG group
There was highly significant improvement in anginal symptoms at 6m and 12m follow up. P <0.0001 as shown Table ( 6) with 1 patient died at 6 month FU and another patient at 12 months FU. No significant difference between two groups
Dyspnea Grade (NYHA Class)
There was highly significant improvement in NYHA class after PCI; P<0.0001 and after CABG; P <0.0001 but no significant difference between two groups as shown in Table ( 6) and figure (2). 
Table6. Follow up (FU) angina CCS and dyspnea grade (NYHA class) at 6 m & 12 in both groups
Revascularization of Left Anterior Descending Coronary Artery Chronic Total Occlusion by Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting (Early and Mid Term Outcome)
Fig1. Follow up angina class in both groups.
Fig2
. Follow up NYHA class in both groups.
Echocardiographic Follow Up Results
LV dimensions and EF
There was a significant reduction of LVESD and LVEDD and improvement in systolic function EF in both groups with no statistically significant difference between two groups table (7, 8) and figure (3).
Figures 4 represents one of our cases with CTO LAD revascularization through PCI with 2 DES. Major adverse cardiac events follow up results: Coronary angiography was repeated when indicated in 6 patients (15%) in PCI group revealing significant lesions that need repeat revascularization in 5 patients (12.5%) 4 patients for LAD ( 3 patients with PCI and one patient with CABG) and one patient for RCA treated by PCI. While in CABG group it was repeated in 3 patients (7.5%) revealing significant lesion that need repeat revascularization through PCI in 2 patients (5 %) both in non LAD lesions (LCX and RCA).
Table7. Follow up LV systolic and diastolic dimensions in both groups
In Hospital MACE
In CABG group 1 patient died during the 2 nd day after procedure due to occurrence of mediastinitis and multiorgan failure. In the PCI group, one patient died suddenly 6 hours after procedure due to ventricular fibrillation inspite attempt of resuscitation. One patients of the PCI group developed acute anterior MI following acute stent thrombosis 4 hours after the procedure and the patient underwent emergency coronary angiography and the thrombus is aspirated by thrombus aspiration catheter (Diver C) successfully. Acute MI occurred in one patient in the CABG group at the 2nd day post operative diagnosed by rising of serum cardiac troponins and ECG changes of Inferior MI, it was due to venous graft thrombosis and treated successfully by medical treatment. The patient didn't need repeat revascularization. Acute onset stroke occurred in one patient in CABG group at 3rd day post operative, presented as right hemiparesis diagnosed by CT brain (ischemic infarction) with partial improvement on medical therapy. No significant difference between both groups as regard occurrence of in hospital MACE; P=1.00 as shown in Table (9) 
Follow up at 6 Months
One patient in PCI group developed stroke 6 months after PCI manifested as complete hemiplegia diagnosed by CT brain as cerebral hemorrhage and treated with partial improvement of motor power.1 patient in PCI group died 4 months after procedure due to cardiogenic shock. (This patient had baseline low EF 37%). 2 patients in PCI had repeat revascularization, at 3 and 5 months after procedure due to development of UA to whom coronary angiography (CA) was done revealing significant instent restenosis ISR of LAD and treated by PCI with DES . No patients in CABG group needed repeat revascularization in 6 moths follow up as shown in Table (9) 8.6. Follow up at 12 Months 1 patient died 8 months after CABG by sudden death, 1 patient in PCI group died 4 months after procedure due to cardiogenic shock. (This patient had baseline low EF 37%).1 patient in CABG group developed acute anterior MI 11 months after the procedure diagnosed by typical chest pain, raised ST segment in V1-3 with raised cardiac troponin level and thrombolytic therapy was given. Later CA revealed insignificant stenos is (30%) in LIMA to LAD. 1 patient in PCI group developed acute anterior MI 11 months after PCI and coronary angiography revealed late stent thrombosis, attempt was done to aspirate instent thrombus but failed so the patient send for surgeons for CABG for repeat revascularization.1 patient in PCI group had repeat revascularization due to significant instent restenosis (ISR) occurred 8m post PCI. The patient was treated by drug eluting balloon (Dior Paclitaxel eluting balloon) to RCA. 2 patients in CABG group needed repeat revascularization due to total occlusion occurred in SVG to LCX and RCA at 8 and 10 months post operative and was treated by DES to native LCX and RCA. 
DISCUSSION
Chronic total occlusion (CTO) of coronary arteries is the last stage of coronary artery atherosclerosis, accounting for one third of the disease confirmed by coronary angiography. 16 CTO exists in about 50% of patients with CAD, which is often accompanied by complex lesions, in about 15% patients as reported. This disease can result in myocardial ischemia, ventricular remodeling which lead to decreased myocardial contractile, reduction of quality of life and poor prognosis. 17
PCI is a therapeutic procedure used not only to recanalize vessels with total occlusion but also widely used in other aspects such as increase blood flow reperfusion, improve myocardial ischemia and left ventricular remodeling and decrease adverse cardiac events .
18, 19
PCI for a CTO remains a major challenge in interventional cardiology, despite the notable advances of novel technologies and procedural techniques, including the use of DES. CTO is defined as an estimated ≥ 3-month-old obstruction of a native coronary artery without any luminal continuity and TIMI grade 0 flow. 20
Although the revascularization decision is more straightforward in patients with CTO and LM/MV CAD, patients with symptomatic isolated CTO represent a challenge for which revascularization decisions should be made. Medical treatment may not be sufficient to relieve symptoms or to improve long-term outcomes, and CABG may be seemed too invasive for single-vessel disease. Therefore, most patients will be referred for PCI. 21
PCI to CTO is now a well-accepted revascularization procedure. With average recanalization success rates of > 70% in experienced hands using contemporary CTO techniques, the presence of a CTO should not be a sufficient reason to switch from a percutaneous towards a surgical approach in MV CAD and the success rate is increased in selected patients with favorable angiographic criteria as short segment, presence of stump and absence of severe calcifications. 22 Successful PCI for CTO has been shown to alleviate anginal symptoms, improve LVEF, decrease the need for CABG, and prolong life. 23
To the best of our knowledge, there are no trials comparing specifically outcomes following CABG or PCI in specifically LAD CTO patients. The SYNTAX trial assessed the optimal method of revascularization for patients with MV CAD of whom around one-quarter in each treatment arm had at least one CTO. 21 Overall, the trial found that as the complexity and extent of coronary disease increased (as assessed by the SYNTAX score), MACE rates increased at 3 years in patients treated with PCI compared with CABG. 24
The present study aims to compare the short & intermediate term outcomes of successful revascularization of CTO of LAD by PCI and CABG.
The current study revealed no significant difference between both groups before revascularization as regard degree of angina class, NYHA class and echocardiographic data. All patients had CTO in LAD, with 11 patients (27.5%) in PCI group had 2 VD versus 16 patients (40%) in CABG group.
As regard symptoms relieve, current study revealed significant and comparable improvement in angina CCS class and NYHA class after revascularization of CTO by either PCI or CABG. According the present investigation, there was no significant difference in incidence of mortality, MI and stroke between both groups at 1 year follow-up. The total MACE was higher in the PCI group than the CABG group and this was largely attributed to higher rate of repeat revascularization in the PCI patients than in CABG patients.
Prior information on relative long-term outcomes for CABG and stent implantation has been documented in many randomized, controlled trials with variable numbers of patients (123 to 1205 patients in each study). During follow-up periods ranging from one to three years, one of these studies found significantly lower mortality rates after CABG 42 . On the other hand Goy et al, (2000) 43 found significantly higher mortality rates after CABG. The presented results also coincided with those recently reported by Natasza et al, (2013) 51 who find that DES implantation during PCI for single CTO reduces MACE rate at 1-year and long-term followup due to the significant reduction of TLR in the DES group.
STUDY LIMITATIONS
 Non randomization in choosing the type of revascularization procedure.
 Selection of patients with CTO either single vessel or 2 vessel disease with favorable angiographic characters for PCI.
 Relative small number of patients included in this study is a problem attributed to that it is a single centre study and to the special inclusion criteria made in this research to evaluate only LAD CTO revascularization.
 Studying the short and intermediate outcomes only.
 Inter and intra observer variability coefficients for the echocardiographic parameters reduced as possible but still to be considered.
 Large randomized clinical trials are needed to accurately assess and compare long term outcomes of treating patient with CTO with either PCI or CABG.
SUMMARY AND CONCLUSION
Successful revascularization of LAD CTO by PCI is a relatively safe procedure and it revealed significant and comparable improvement in angina class and NYHA class in comparison with a more invasive procedure which is CABG. Also the results of current study showed significant and comparable improvement of LV dimensions, EF and degree of MR in both groups. On the other hand these data revealed no significant difference in mortality, MI and stroke in both groups, but the overall MACE was slightly higher in patients revascularized by PCI than in individuals underwent CABG due to higher rate of repeat revascularization in PCI group specially with good selection of patients with suitable angiographic criteria for attempt PCI. PCI to CTO is an effective therapeutic procedure with an acceptable high success rate & low incidence of complications in patients with good selection criteria. 
